Cannabis has recently been found to be an effective treatment for patients with multiple sclerosis, according to new research. While it was once believed that the symptomatic changes encountered by patients with multiple sclerosis who were given cannabinoid drugs were largely due to psychological factors, later research has shown that cannabis actually decreases the muscle spasms and stiffness that are common in MS patients. Short- and long-term randomised medical trials have documented the beneficial effects of cannabis on patients with multiple sclerosis.Do you want to learn more? Visit Top Shelf Wellness Center Recreational Marijuana Dispensary – cannabis
The findings of a series of short- and long-term studies on the effects of cannabinoids in patients with multiple sclerosis were published in 2003 by a team of researchers from the Peninsula Medical School in Exeter, UK. Around 600 patients with advanced-stage multiple sclerosis participated in previous trials. Over the course of 15 weeks, the participants were split into two groups: the first received cannabinoid compounds in equivalent doses, while the second received placebo drugs. By the end of the study, the majority of patients who were given cannabinoids had reported significant symptomatic changes, with less muscle pain and milder muscular spasticity (less pronounced muscular spasm). The control group (patients who received placebo medications) did not change their overall condition as much as the group that received cannabinoid compounds over the course of the trial.
The study was later replicated to affirm the relevance of the results and to dispel any concerns about the efficacy of cannabis in alleviating the symptoms of multiple sclerosis. The subsequent research took place over a 12-month period and included the same subjects. However, instead of the previous experiment’s two distinct groups, this time the participants were split into three distinct groups. The first group was given D9-tetrahydrocannabinol (THC) tablets, the active ingredient in cannabis, the second group was given natural cannabis extracts, and the third group was given placebo pills.
Patients were assessed and tested by a team of physiotherapists and neurologists at the conclusion of the study. The patients in the first research group had the greatest outcomes, with the majority of those who received equivalent doses of THC seeing significant changes in their symptoms. Patients in the second study group saw minor improvements in their symptoms, while those in the third study group saw little difference in their condition.
Despite the fact that these findings clearly show that cannabis is an effective therapy for multiple sclerosis, medical scientists remain sceptical about the efficacy of cannabinoids in the treatment of multiple sclerosis. Doctors may suggest introducing cannabinoid compounds in the treatment of multiple sclerosis in the near future after conducting additional research and studies on the topic.